Carballo-Carbajal, Iria https://orcid.org/0000-0002-4403-8006
Laguna, Ariadna https://orcid.org/0000-0002-9732-6677
Romero-Giménez, Jordi https://orcid.org/0000-0002-8459-9895
Cuadros, Thais
Bové, Jordi
Martinez-Vicente, Marta https://orcid.org/0000-0001-7053-2625
Parent, Annabelle https://orcid.org/0000-0002-6195-812X
Gonzalez-Sepulveda, Marta
Peñuelas, Núria https://orcid.org/0000-0001-6443-9790
Torra, Albert https://orcid.org/0000-0002-6852-7146
Rodríguez-Galván, Beatriz
Ballabio, Andrea https://orcid.org/0000-0003-1381-4604
Hasegawa, Takafumi
Bortolozzi, Analía https://orcid.org/0000-0002-2069-9192
Gelpi, Ellen https://orcid.org/0000-0003-2948-4187
Vila, Miquel https://orcid.org/0000-0002-1352-989X
Article History
Received: 26 November 2018
Accepted: 28 January 2019
First Online: 7 March 2019
Competing interests
: VHIR has applied for a use patent for the modulation of neuromelanin levels in the treatment of Parkinson's disease and/or brain aging.